"Wall Street's outlook is for a 17% rise in EPS to 21 cents on a 5% climb in revenue to $670.8 million. If it tops estimates, it will make an even four quarters in a row." IBD
"Analysts look for a 37% EPS increase to $1.23, and for sales to rise 13.7% to $889.2 million" IBD
Looks like market is long on Monday afternoon's earnings release
Looks like a lot post-tax sell-off money went to healthcare
Sector rotation into transports, financials?
All indicators at top range, strong RS vs SPY
Watching this closely if it holds cup pattern, or falls below TL and into possible cloud.
Short cup pattern, not a huge shakeout, so could be weak
More likely than not that this name will continue lower for the next couple of weeks. 420, 400, 360 next possible stopping points.
Interesting how BAC drags down FAS certain days but not others? $FAS $BAC $C $JPM